The Scientific Committee


The scientific committee comprises one member with scientific competence from each member country appointed by the NCU Board after recommendations from the national cancer societies.

The tasks of the committee are:
• to assess scientific grant applications, secure high scientific quality and formulate recommendations regarding the applications to the Secretaries-General for their decisions on grants
• to give consultation concerning strategic projects regarding research to the Secretaries-General for their decisions on grants
• to evaluate funded research and follow-up on the application of the results in the Nordic countries

The scientific committee is invited to an annual meeting and to the meeting for the Committee of Representatives held every third year.
 

Medlemmer af NCU’s Videnskabelige Komité  2015-2018

 

From Island:

Thorunn Rafnar, Biolog, Ph.D, afdelingsleder i Cancer Decode Genetics, Island.

Formand for komitéen.

 

From Færøerne:

Johan Poulsen, overlæge og urolog på afdelingen for Urologi på Ålborg Universitetshospital, Danmark. Derudover deltids urolog på Kings College Hospital, London

 

From Danmark:

Elsebeth Lynge, professor, mag.scient.soc, ved Institut for Folkesundhedsvidenskab, Danmark.

 

From Finland:

Klaus Peter Elenius, Phd, Professor of medical biochemistry, University of Turku, Finland.

 

From Sverige:

Klas Kärre, Phd, Professor i molekylär immunologi vid Karolinska Institutet og ordförande i Cancerfondens forskningsnämnd.

 

From Norge:

Tom K. Grimsrud, Phd, overlege, gruppe for etiologisk forskning hos Kræftregisteret, Norge.

 


Medlemmer af NCU’s Videnskabelige Komité  2012-2014

 

From the Faroe Islands:
Johan Poulsen, chairman of the committee. Physician and urologist at the Division of Urology at Aalborg University, Denmark. In addition, part-time urologist at King's College Hospital, London

From Denmark:
Elsebeth Lynge, Professor, mag.scient.soc, at the Department of Public Health, Denmark.

From Finland:
Jorma Keski-Oja, Professor at Helsinki Universitet, Finland.

From Sweden:
Eva Hellström Lindberg, Professor, physician, researcher, employed at the Karolinska University Hospital, Huddinge.

From Norway:
Kristina Kjærheim, Chief and Deputy Head of Department for Research in Cancer Registry, Norway.

From Iceland:
Asgerður Sverrisdóttir, consultant and employee of "Landsspitali" in Iceland, member of the committee.
Thorunn Rafnar, Biologist, Ph.D., Head of Cancer Decode Genetics, Iceland, is an alternate member of the Board from September to 1 January 2013 while Ásgerður Sverrisdóttir is on leave.